케이바이오랩스
038530KOSDAQ생활용품 도매업64.0 / 100
Reference Date: 2026-07-24
Company InformationBased on 2025 Annual Report
Business Overview
KEBIO operates in two main sectors: bio-distribution of life science equipment and reagents, and ICT solutions including hardware, software, and IT services. Since acquiring CureBio's distribution division in 2021, the company has expanded its bio-distribution business, leveraging over 20 years of experience. Additionally, it is broadening its ICT offerings by developing IoT-based security solutions, such as large-scale integrated control systems and smart policing services, building on its expertise in video security technology.
Number of Employees
38people
Average Salary
49.4M KRW
Score Calculation Basis
Detailed Financial Score
Half of industry avg (excellent)
Well below industry avg
Half of industry avg (excellent)
Avg ▲97.1% (2-year basis)
Avg ▲166.6% (2-year basis)
Avg ROE -8.8% (improving, 3yr)
Detailed News Sentiment
- Positive농식품 유망 스타트업과 투자사 연결… 사업화 기회 활짝
케이바이오랩스는 농식품 테크 스타트업 분야에서의 네트워킹 기회 확대로 인해 긍정적인 사업화 가능성 증가.
- Positive케이바이오랩스, 5대 1 주식병합 결정
케이바이오랩스의 주식병합 결정으로 인해 주식 수가 줄어들어 자본 효율성이 향상될 것으로 예상됩니다.
Detailed Momentum
52w mid range (45%)
1m -7.19% (falling)
Volume dry-up
Detailed Disclosure
- Neutral주식병합결정2026-07-16
- Neutral[기재정정]주주총회소집결의 (임시주주총회)2026-07-16
- Neutral주식등의대량보유상황보고서(일반)2026-07-16
- Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-07-16
- Neutral증권발행결과(자율공시)2026-07-14
